Q3 2026 13F filing
Updated 6 days ago36 disclosed positions worth $2.3B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | Z ZYMEWORKS INC | $608.5M | 22.97M | 27.01% | — |
| 2 | A ANAPTYSBIO INC | $396.1M | 7.88M | 17.58% | — |
| 3 | C BRISTOL-MYERS SQUIBB CO | $218.4M | 3.50M | 9.70% | — |
| 4 | C CG ONCOLOGY INC | $132.7M | 1.87M | 5.89% | — |
| 5 | E ETON PHARMACEUTICALS INC | $127.2M | 2.47M | 5.65% | — |
| 6 | T FIRST TRACKS BIOTHERAPEUTICS | $112.5M | 3.17M | 4.99% | — |
| 7 | A AKTIS ONCOLOGY INC | $93.9M | 4.82M | 4.17% | — |
| 8 | C CRISPR THERAPEUTICS AG | $76.9M | 1.39M | 3.41% | — |
| 9 | A ALTO NEUROSCIENCE INC | $57M | 2.23M | 2.53% | — |
| 10 | G LAKEFRONT BIOTHERAPEUTICS NV | $49.4M | 1.67M | 2.19% | — |
| 11 | E ERASCA INC | $43.2M | 2.95M | 1.92% | — |
| 12 | O ORIC PHARMACEUTICALS INC | $40.8M | 3.03M | 1.81% | — |
| 13 | N NEUROGENE INC | $35.4M | 1.27M | 1.57% | — |
| 14 | ? N/A ATTOVIA THERAPEUTICS INC | $34.7M | 2.02M | 1.54% | — |
| 15 | ? N/A FULCRUM THERAPEUTICS INC | $25.2M | 6.80M | 1.12% | — |
| 16 | A ADARX PHARMACEUTICALS INC | $22.9M | 1.15M | 1.02% | — |
| 17 | S STOKE THERAPEUTICS INC | $21.7M | 835.0K | 0.96% | — |
| 18 | Z ZENAS BIOPHARMA INC | $21.3M | 789.5K | 0.95% | — |
| 19 | ? N/A ELECTRA THERAPEUTICS INC | $19.1M | 1.70M | 0.85% | — |
| 20 | ? N/A ATARA BIOTHERAPEUTICS INC | $13.2M | 1.55M | 0.59% | — |
| 21 | C CAPRICOR THERAPEUTICS INC | $13M | 1.38M | 0.58% | — |
| 22 | X XENCOR INC | $12.5M | 500.0K | 0.55% | — |
| 23 | O ODYSSEY THERAPEUTICS INC | $12.3M | 555.6K | 0.55% | — |
| 24 | A AURA BIOSCIENCES INC | $10.5M | 1.67M | 0.46% | — |
| 25 | N NURIX THERAPEUTICS INC | $8.9M | 375.0K | 0.39% | — |
| 26 | ? N/A BRAVEHEART BIO INC | $8.4M | 416.7K | 0.37% | — |
| 27 | P PHARVARIS N V | $7.5M | 235.0K | 0.33% | — |
| 28 | E EIKON THERAPEUTICS INC | $6.9M | 855.6K | 0.31% | — |
| 29 | ? N/A ELOXX PHARMACEUTICALS INC | $6.1M | 400.0K | 0.27% | — |
| 30 | ? N/A AARDVARK THERAPEUTICS INC | $3.8M | 720.0K | 0.17% | — |
| 31 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $3.6M | 889.6K | 0.16% | — |
| 32 | ? N/A TCGX ACQUISITION CORP | $3.1M | 250.0K | 0.14% | — |
| 33 | Z ZURA BIO LTD | $2.8M | 679.7K | 0.13% | — |
| 34 | ? N/A HELIX ACQUISITION CORP III USD | $2.1M | 200.0K | 0.09% | — |
| 35 | C CONTINEUM THERAPEUTICS INC | $863K | 64.3K | 0.04% | — |
| 36 | C CG ONCOLOGY INC | $7K | 100 | 0.00% | — |